NO980422L - Endotelinreseptorantagonister - Google Patents

Endotelinreseptorantagonister

Info

Publication number
NO980422L
NO980422L NO980422A NO980422A NO980422L NO 980422 L NO980422 L NO 980422L NO 980422 A NO980422 A NO 980422A NO 980422 A NO980422 A NO 980422A NO 980422 L NO980422 L NO 980422L
Authority
NO
Norway
Prior art keywords
endothelin
Prior art date
Application number
NO980422A
Other languages
English (en)
Norwegian (no)
Other versions
NO980422D0 (no
Inventor
Juan Ignacio Luengo
John Duncan Elliott
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO980422D0 publication Critical patent/NO980422D0/no
Publication of NO980422L publication Critical patent/NO980422L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO980422A 1995-08-02 1998-01-30 Endotelinreseptorantagonister NO980422L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1098296P 1996-02-01 1996-02-01
PCT/US1996/012581 WO1997004772A1 (en) 1995-08-02 1996-08-02 Endothelin receptor antagonists

Publications (2)

Publication Number Publication Date
NO980422D0 NO980422D0 (no) 1998-01-30
NO980422L true NO980422L (no) 1998-03-24

Family

ID=26669471

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980422A NO980422L (no) 1995-08-02 1998-01-30 Endotelinreseptorantagonister

Country Status (25)

Country Link
US (5) US5969151A (cs)
EP (2) EP0841925B1 (cs)
JP (2) JPH11511133A (cs)
KR (1) KR19990036032A (cs)
CN (1) CN1196680A (cs)
AP (1) AP9801182A0 (cs)
AT (1) ATE341324T1 (cs)
AU (2) AU6646396A (cs)
BG (1) BG102229A (cs)
BR (1) BR9609914A (cs)
CA (2) CA2228296A1 (cs)
CZ (1) CZ30498A3 (cs)
DE (2) DE69619116T2 (cs)
EA (1) EA000952B1 (cs)
ES (2) ES2171697T3 (cs)
HU (1) HU220776B1 (cs)
MX (1) MX9800975A (cs)
NO (1) NO980422L (cs)
NZ (1) NZ315846A (cs)
OA (1) OA10755A (cs)
PL (1) PL184272B1 (cs)
RO (1) RO115802B1 (cs)
SK (1) SK282584B6 (cs)
TR (1) TR199800152T1 (cs)
WO (2) WO1997004772A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017426A1 (es) 1997-12-08 2001-09-05 Smithkline Beecham Corp Sal de monoargininilo del acido (e)-3-[1-n-butil-5-[2-(2-carboxifenil)metoxi-4-clorofenil]-1h-pirazol-4-il]-2-[(5-metoxi-2,3-dihidrobenzofuran-6-il)metil]-prop-2-enoico, composicion farmaceutica que la contiene, su uso para la manufactura de un medicamento y procedimiento para su preparacion
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
JP2006501179A (ja) * 2002-06-27 2006-01-12 ニトロメッド インコーポレーティッド シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
US10626096B2 (en) 2015-11-24 2020-04-21 Sanford Burnham Prebys Medical Discovery Institute Azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AU9137791A (en) * 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
DE69426698T2 (de) * 1993-08-18 2001-08-16 Banyu Pharmaceutical Co., Ltd. Kondensierte heteroaromatische cyclopentenderivate mit endothelin-antagonistischer aktivität
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
WO1996007653A1 (en) * 1994-09-02 1996-03-14 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
ATE341324T1 (de) 2006-10-15
ES2273350T3 (es) 2007-05-01
JP2001517195A (ja) 2001-10-02
TR199800152T1 (xx) 1998-05-21
MX9800975A (es) 1998-04-30
NO980422D0 (no) 1998-01-30
EP0843551B1 (en) 2002-02-06
HU220776B1 (hu) 2002-05-28
CN1196680A (zh) 1998-10-21
EP0843551A4 (en) 1998-08-12
EP0841925A4 (en) 2001-10-17
BG102229A (en) 1998-09-30
CZ30498A3 (cs) 1998-07-15
OA10755A (en) 2002-12-13
BR9609914A (pt) 1999-07-06
AP9801182A0 (en) 1998-01-31
US5958968A (en) 1999-09-28
EA199800185A1 (ru) 1998-10-29
WO1997004772A1 (en) 1997-02-13
US6482956B2 (en) 2002-11-19
DE69619116T2 (de) 2002-09-19
NZ315846A (en) 1999-01-28
US5969151A (en) 1999-10-19
JPH11511133A (ja) 1999-09-28
EA000952B1 (ru) 2000-08-28
HUP9902817A2 (hu) 1999-12-28
SK11398A3 (en) 1998-07-08
EP0841925B1 (en) 2006-10-04
DE69619116D1 (de) 2002-03-21
HUP9902817A3 (en) 2001-03-28
SK282584B6 (sk) 2002-10-08
KR19990036032A (ko) 1999-05-25
PL184272B1 (pl) 2002-09-30
DE69636597T2 (de) 2007-08-16
AU717172B2 (en) 2000-03-16
EP0843551A1 (en) 1998-05-27
AU6764596A (en) 1997-02-26
US6353116B1 (en) 2002-03-05
CA2228296A1 (en) 1997-02-13
WO1997004773A1 (en) 1997-02-13
ES2171697T3 (es) 2002-09-16
PL324745A1 (en) 1998-06-08
CA2228293A1 (en) 1997-02-13
RO115802B1 (ro) 2000-06-30
US20020072614A1 (en) 2002-06-13
AU6646396A (en) 1997-02-26
EP0841925A1 (en) 1998-05-20
DE69636597D1 (de) 2006-11-16
US6096897A (en) 2000-08-01

Similar Documents

Publication Publication Date Title
NO961072L (no) Endotelinreseptorantagonister
DE69619116D1 (de) Endothelinrezeptorantagonisten
NO963131D0 (no) Endotelinreseptorantagonister
DE69626986D1 (de) Endothelinrezeptorantagonist
NO963213D0 (no) Endotelinreseptorantagonister
DE69628924D1 (de) Endothelinrezeptorantagonisten
FI964165A0 (fi) Kopplingsklo foer skjutarm
ATE240972T1 (de) Cyclopeptolide
FIU950271U0 (fi) Musunderlag
BR9501643A (pt) Helistato
BR9503866A (pt) Autolabor
SE9501165D0 (sv) Hållaranordning
FI2161U1 (fi) Skyddshattsarrangemang
KR960030307U (ko) 다시
BR7500192U (pt) Parasitofiltro
BR7501298U (pt) Torre-audio-visual
BR7500703U (pt) Rodopratic
BR7500437U (pt) Girolight
BR7500040U (pt) Raquet mastit
BR7500825U (pt) Chutegol
BR7501828U (pt) Multicopo
BR7500838U (pt) Vassourágua
KR970011857U (ko) 밸트스타킹
BR7500991U (pt) Caríndio
BR7501303U (pt) Dupla-embalagem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application